Lindsey Lekhraj – Trademark Portfolio

Entity Type: 01

Lindsey Lekhraj holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include WISHCRAFT, BODY BY DESIGN, and DESIGNER GENES. The owner is based in Burbank, CA.

1833 N Frederic St

Burbank, CA 91505

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lindsey Lekhraj's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Lindsey Lekhraj have?

Lindsey Lekhraj has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does Lindsey Lekhraj file in?

Lindsey Lekhraj files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Lindsey Lekhraj's most well-known trademarks?

Lindsey Lekhraj's registered trademark portfolio includes well-known marks such as WISHCRAFT, BODY BY DESIGN, and DESIGNER GENES. These are among 3 currently registered trademarks in the portfolio.

What is Lindsey Lekhraj's trademark registration success rate?

Lindsey Lekhraj has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.